Innovative drug approvals (half year)
STO-REC-STATWZQGKCT1 Official
38
China · as of 30 Jun 2026
Innovative drug approvals in China (half year) stood at 38 as of 30 June 2026 (State Council).
- Publisher
- State Council
- Authority tier
- T1 Official
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
China approved 38 innovative drugs for marketing during the period, including 31 developed by domestic companies, Tao Qing, head of the bureau for operation, monitoring and coordination with the MIIT, told a media conference.
Verbatim extraction verified: The figure 38 is directly attested in the quoted passage (Value of China's innovative drug out-licensing deals hit new high in H1).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2
- MLA
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026, https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2.
- Chicago
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026. https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2.
- BibTeX
- @misc{statecouncil2026innovativehbw2d2, author = {{State Council of China}}, title = {Value of China's innovative drug out-licensing deals hit new high in H1}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2}, note = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Value of China's innovative drug out-licensing deals hit new high in H1
- Type
- Press release
- Published
- —
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2